Cytomegalovirus Prophylaxis With Letermovir in Heart Transplant Recipients: A Non-randomized Cohort Pilot Study
Latest Information Update: 19 Sep 2024
At a glance
- Drugs Letermovir (Primary)
- Indications Cytomegalovirus infections
- Focus Therapeutic Use
- Acronyms CYPHER-TXPilot
Most Recent Events
- 18 Sep 2022 Status changed from not yet recruiting to recruiting.
- 29 Jun 2022 New trial record